On Friday, a majority of experts on the panel expressed support for classifying ECT devices as high risk for the treatment of depression and several other conditions.
For decades psychiatrists have used shock therapy to treat cases of depression that haven't been helped by antidepressant medications, and in recent years the treatment -- now known as electroconvulsive therapy (ECT) -- has experienced something of a revival.
On Thursday, a Food and Drug Administration (FDA) advisory panel will meet to consider whether the machines used in ECT should be more tightly regulated than they are now.